Keating, Gillian M. - In: PharmacoEconomics 29 (2011) 6, pp. 535-543
Intravenous esomeprazole (Nexium) is approved in Europe for the prevention of rebleeding following therapeutic endoscopy for acute bleeding gastric or duodenal ulcers. In a pivotal clinical trial, patients with peptic ulcer bleeding and high-risk stigmata who received intravenous esomeprazole...